Answer
The most common adverse reactions reported with vorasidenib, including laboratory abnormalities, were increased ALT (59.3%), increased AST (45.5%), increased GGT (37.7%), fatigue (36.5%) and diarrhoea (24.6%).
Sources for this answer
- Voranigo 10 mg film-coated tabletServier Laboratories Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked